About Affimed (AFMD)
Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research t... Read more
- USD0.22
- USD0.24
- USD0.17
- USD8.95
- -42.50%
- 1M
- 113.25k
- 9M
- 0.52
- -91.20%
Stock News
last year
Why Tuesday's pullback is a healthy break in the rally and how we are playing it
CNBC
last year
ESPN Bet plans launch in New York, the largest U.S. betting market
CNBC
last year
Moving to New York City? Be ready to drop more than $10,000 up front to rent an apartment.
MarketWatch
last year
Tesla leads 11% annual drop in EV prices as demand slowdown continues
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
